Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID), 20963 [E9-10554]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 86 / Wednesday, May 6, 2009 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: July 14–15, 2009.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza—Tyson Corner, 1960
Chain Bridge Road, McLean, VA 22102.
Contact Person: Lorraine Gunzerath, PhD,
MBA Scientific Review Officer, National
Institute on Alcohol Abuse and Alcoholism,
Office of Extramural Activities, Extramural
Project Review Branch, 5635 Fishers Lane,
Room 2121, Bethesda, MD 20892–9304, 301–
443–2369, lgunzera@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: April 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–10409 Filed 5–5–09; 8:45 am]
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
Jkt 217001
Dated: April 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–10408 Filed 5–5–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Board of Scientific Counselors,
Coordinating Center for Infectious
Diseases (CCID)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
18:36 May 05, 2009
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group Neuroscience Review
Subcommittee.
Date: July 13–14, 2009.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Beata Buzas, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Rm
2081, Rockville, MD 20852, 301–443–0800,
bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Centers for Disease Control and
Prevention
BILLING CODE 4140–01–M
VerDate Nov<24>2008
would constitute a clearly unwarranted
invasion of personal privacy.
Notice of Cancellation: This notice
was published in the Federal Register
on April 13, 2009, Volume 74, Number
69, page 16877. The meeting previously
scheduled to convene on May 14, 2009
has been cancelled due to the public
health emergency.
Contact Person for More Information:
Harriette Lynch, Office of the Director,
CCID, CDC, Mailstop E–77, 1600 Clifton
Road, NE., Atlanta, Georgia 30333, email hlynch@cdc.gov, telephone (404)
498–2726.
The Director, Management Analysis
and Services office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
20963
Dated: May 1, 2009.
Andre Tyler,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–10554 Filed 5–4–09; 11:15 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Transmissible Spongiform
Encephalopathies Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Transmissible
Spongiform Encephalopathies Advisory
Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on June 12, 2009, from 8 a.m. to
5:45 p.m.
Location: Holiday Inn Gaithersburg,
Grand Ballroom, 2 Montgomery Village
Ave., Gaithersburg, MD.
Contact Person: William Freas or
Rosanna Harvey, Center for Biologics
Evaluation and Research (HFM–71),
Food and Drug Administration, 1401
Rockville Pike, Rockville, MD 20852–
1448, 301–827–0314, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), code 301–451–
2392. Please call the Information Line
for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the agency’s Web
site and call the appropriate advisory
committee hot line/phone line to learn
about possible modifications before
coming to the meeting.
Agenda: On June 12, 2009, the
Committee will review and discuss a
recent report from the UK Health
Protection Agency attributing a case of
variant Creutzfeldt-Jakob (vCJD) disease
infection to treatment 11 years earlier
E:\FR\FM\06MYN1.SGM
06MYN1
]]>Agencies
[Federal Register Volume 74, Number 86 (Wednesday, May 6, 2009)]
[Notices]
[Page 20963]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10554]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Coordinating Center for
Infectious Diseases (CCID)
Notice of Cancellation: This notice was published in the Federal
Register on April 13, 2009, Volume 74, Number 69, page 16877. The
meeting previously scheduled to convene on May 14, 2009 has been
cancelled due to the public health emergency.
Contact Person for More Information: Harriette Lynch, Office of the
Director, CCID, CDC, Mailstop E-77, 1600 Clifton Road, NE., Atlanta,
Georgia 30333, e-mail hlynch@cdc.gov, telephone (404) 498-2726.
The Director, Management Analysis and Services office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: May 1, 2009.
Andre Tyler,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E9-10554 Filed 5-4-09; 11:15 am]
BILLING CODE 4163-18-P
